Dr Brahmer’s research paved the way for the first immunotherapy agent to receive US Food and Drug Administration approval for the treatment of lung cancer.
Combination Immunotherapy Approaches: A five-part video roundtable series
This is Part 1 of Appropriate Management of Challenging Cases in Lung Cancer, a five-part video roundtable series. Scroll down to watch the other videos from this Roundtable. View Video
This is Part 2 of Appropriate Management of Challenging Cases in Lung Cancer, a five-part video roundtable series. Scroll down to watch the other videos from this Roundtable. View Video
This is Part 3 of Appropriate Management of Challenging Cases in Lung Cancer, a five-part video roundtable series. Scroll down to watch the other videos from this Roundtable. View Video
This is Part 4 of Appropriate Management of Challenging Cases in Lung Cancer, a five-part video roundtable series. Scroll down to watch the other videos from this Roundtable. View Video
This is Part 5 of Appropriate Management of Challenging Cases in Lung Cancer, a five-part video roundtable series. Scroll down to watch the other videos from this Roundtable. View Video